Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Mo | AJJ MEDTECH HOLDINGS LIMITED: REPL::EXTRAORDINARY/ SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
Mo | AJJ MEDTECH HOLDINGS LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
12.04. | AJJ MEDTECH HOLDINGS LIMITED: EXTRAORDINARY/ SPECIAL GENERAL MEETING::VOLUNTARY | 320 | SGX Company Announcements | ||
12.04. | AJJ MEDTECH HOLDINGS LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | 320 | SGX Company Announcements | ||
12.04. | AJJ MEDTECH HOLDINGS LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 84 | SGX Company Announcements | ||
12.04. | AJJ MEDTECH HOLDINGS LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::AUDITOR'S COMMENTS OF ACCOUNTS | 17 | SGX Company Announcements | ||
13.03. | AJJ MEDTECH HOLDINGS LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
12.03. | AJJ MEDTECH HOLDINGS LIMITED: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/ UNITHOLDER(S)::DISCLOSURE OF INTEREST OF SUBSTANTIAL SHAREHOLDER | 1 | SGX Company Announcements | ||
08.03. | AJJ MEDTECH HOLDINGS LIMITED: CHANGE - CHANGE IN CORPORATE INFORMATION::CHANGE OF ADDRESS OF SHARE REGISTRAR AND PLACE WHERE REGISTER OF MEMBERS AND INDEX IS KEPT | 1 | SGX Company Announcements | ||
07.03. | AJJ MEDTECH HOLDINGS LIMITED: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::CHANGES IN INTEREST OF THE DIRECTOR | 1 | SGX Company Announcements | ||
06.03. | AJJ MEDTECH HOLDINGS LIMITED: GENERAL ANNOUNCEMENT::MINUTES OF THE EXTRAORDINARY GENERAL MEETING OF THE COMPANY HELD ON 6 FEBRUARY 2024 | 1 | SGX Company Announcements | ||
05.03. | AJJ MEDTECH HOLDINGS LIMITED: GENERAL ANNOUNCEMENT::COMPLETION OF PROPOSED CAPITALISATION, PROPOSED PLACEMENT AND PROPOSED GRANT OF THE ZYL AWARD | 1 | SGX Company Announcements | ||
29.02. | AJJ MEDTECH HOLDINGS LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::FULL YEARLY RESULTS | 1 | SGX Company Announcements | ||
26.02. | AJJ MEDTECH HOLDINGS LIMITED: PLACEMENTS::RECEIPT OF THE LISTING AND QUOTATION NOTICE FROM SGX-ST | 1 | SGX Company Announcements | ||
26.02. | AJJ MEDTECH HOLDINGS LIMITED: GENERAL ANNOUNCEMENT::RECEIPT OF THE LISTING AND QUOTATION NOTICE FROM SGX-ST | 1 | SGX Company Announcements | ||
19.02. | OEL (HOLDINGS) LIMITED: CHANGE IN ISSUER NAME::MANDATORY | 2 | SGX Company Announcements | ||
06.02. | OEL (HOLDINGS) LIMITED: REPL::EXTRAORDINARY/ SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements | ||
18.01. | OEL (HOLDINGS) LIMITED: RESPONSE TO SGX QUERIES | 9 | SGX Company Announcements | ||
17.01. | OEL (HOLDINGS) LIMITED: PLACEMENTS::PROPOSED PLACEMENT OF 118,285,713 NEW ORDINARY SHARES AT A PLACEMENT PRICE OF S$0.007 PER SHARE | 2 | SGX Company Announcements | ||
11.01. | OEL (HOLDINGS) LIMITED: EXTRAORDINARY/ SPECIAL GENERAL MEETING::VOLUNTARY | 1 | SGX Company Announcements |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 52,10 | -1,21 % | DZ BANK stuft Siemens Healthineers auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für Siemens Healthineers vor Zahlen von 52 auf 53 Euro angehoben und die Einstufung auf "Halten" belassen. Analyst Sven Kürten erwartet... ► Artikel lesen | |
FRESENIUS | 27,970 | +1,05 % | WARBURG RESEARCH stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Das Analysehaus Warburg Research hat das Kursziel für Fresenius von 40 auf 41 Euro angehoben und die Einstufung auf "Buy" belassen. Angesichts des guten Jahresstarts habe... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 39,600 | +2,46 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für FMC vor Quartalszahlen von 29 auf 32 Euro angehoben und die Einstufung auf "Underperform" belassen. Nachdem sich der Dialysespezialist... ► Artikel lesen | |
CARL ZEISS MEDITEC | 99,10 | -1,59 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Buy' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Carl Zeiss Meditec vor Quartalszahlen auf "Buy" mit einem Kursziel von 130 Euro belassen. Die jüngsten Kursverluste dürften... ► Artikel lesen | |
MOBILE-HEALTH NETWORK SOLUTIONS | 24,650 | 0,00 % | Mobile-health Retreats on Opening New Pharmacy | ||
GERRESHEIMER | 101,00 | +0,60 % | Eli Lilly fegt die Prognosen vom Tisch - auch Novo Nordisk, Gerresheimer, Gubra und Co springen ... | Der amerikanische Pharma-Riese Eli Lilly hat die hohen Erwartungen der Marktteilnehmer klar übertreffen können. Vor allem der Boom bei Tirzepatid-basierten Produkten (Diabetes-Mittel Mounjaro und "Abnehmspritze"... ► Artikel lesen | |
GENEDX | 17,130 | 0,00 % | Pre-market Movers: Cyclacel Pharmaceuticals, Marin Software, GeneDx, Sensata Technologies, Lichen China | INDIANAPOLIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.05 A.M. ET).In the Green Cyclacel Pharmaceuticals, Inc. (CYCC) is up... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 18,400 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 52,94 | +1,71 % | PROCEPT BioRobotics Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million | SAN JOSE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
ATRICURE | 24,140 | 0,00 % | AtriCure Q1 2024 Earnings Preview | ||
DOCGO | 3,380 | -6,63 % | Evaluating DocGo: Insights From 8 Financial Analysts | ||
PROGYNY | 32,070 | 0,00 % | Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report | ||
AGILON HEALTH | 5,495 | 0,00 % | agilon health Reports Fourth Quarter 2023 Results | AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the fourth quarter... ► Artikel lesen | |
ECKERT & ZIEGLER | 37,220 | -0,27 % | HAUCK AUFHÄUSER INVESTMENT BANKING stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Hauck Aufhäuser Investment Banking hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 60 Euro auf "Buy" belassen. Das Kerngeschäft des Isotopenspezialisten stehe... ► Artikel lesen | |
BRIGHTSPRING HEALTH SERVICES | 10,690 | -2,02 % | BrightSpring Health Services appoints Timothy Wick to its board of directors |